JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moroz, M. A.
Right arrow Articles by Blasberg, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moroz, M. A.
Right arrow Articles by Blasberg, R. G.
Journal of Nuclear Medicine Vol. 48 No. 5 827-836
© 2007 by Society of Nuclear Medicine

doi: 10.2967/jnumed.106.037812

Basic Science Investigation

Imaging hNET Reporter Gene Expression with 124I-MIBG

Maxim A. Moroz*,1, Inna Serganova*,1, Pat Zanzonico2, Ludmila Ageyeva1, Tatiana Beresten1, Ekaterina Dyomina1, Eva Burnazi3, Ronald D. Finn3–5,, Michael Doubrovin1 and Ronald G. Blasberg1,4,5

1 Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York; 2 Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York; 3 Cyclotron and Radiochemistry Core Facility, Memorial Sloan-Kettering Cancer Center, New York, New York; 4 Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York; and 5 Memorial Hospital Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York

Correspondence: For correspondence or reprints contact: Ronald G. Blasberg, MD, Departments of Neurology and Radiology, MH (Box 52), Molecular Pharmacology and Chemistry Program, SKI, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, New York 10021. E-mail: blasberg{at}neuro1.mskcc.org

The norepinephrine transporter (NET) has recently been suggested as a useful reporter gene. We have extended this effort by constructing an internal ribosomal entry site (IRES)-linked hNET-green fluorescent protein (GFP) hybrid reporter gene for both nuclear and optical imaging. Methods: A retroviral vector pQCXhNET-IRES-GFP was constructed and used to generate several reporter cell lines and xenografts. Transduced cells were sorted by fluorescence-activated cell sorting based on GFP expression and used for both in vitro and in vivo imaging studies. Results: The transduced reporter cells accumulated 123I- or 124I-labeled metaiodobenzylguanidine (MIBG) to high levels compared with the wild-type parent cell lines. Differences in MIBG accumulation between cell lines were primarily due to differences in influx (K1) rather than efflux (k2). The estimated MIBG distribution volumes (Vd) for transduced Jurkat, C6, and COS-7 cells were 572 ± 13, 754 ± 25, and 1,556 ± 38 mL/g, respectively. A correlation between radiotracer accumulation (K1) and GFP fluorescence intensity was also demonstrated. Sequential imaging studies of mice bearing pQCXhNET-IRES-GFP transduced and wild-type C6 xenografts demonstrated several advantages of 124I-MIBG small-animal PET compared with 123I-MIBG {gamma}-camera/SPECT. This was primarily due to the longer half-life of 124I and to the retention and slow clearance (half-time, 63 ± 6 h) of MIBG from transduced xenografts compared with that from wild-type xenografts (half-time, 12 ± 1 h) and other organs (half-time, 2.6–21 h). Very high radioactivity ratios were observed at later imaging times; at 73 h after 124I-MIBG injection, the C6/hNET-IRES-GFP xenograft-to-muscle ratio was 293 ± 48 whereas the C6 xenograft-to-muscle ratio was 0.71 ± 0.19. Conclusion: These studies demonstrate the potential for a wider application of hNET reporter imaging and the future translation to patient studies using radiopharmaceuticals that are currently available for both SPECT and PET.

Key Words: human norepinephrine transporter • 124I-MIBG • 123I-MIBG • PET • {gamma}-camera • SPECT • molecular imaging • reporter gene

* Contributed equally to this work.

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11a-12a. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
J. H. Kang and J.-K. Chung
Molecular-Genetic Imaging Based on Reporter Gene Expression
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 164S - 179S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y. Likar, K. Dobrenkov, M. Olszewska, E. Vider, L. Shenker, S. Cai, N. Pillarsetty, H. Hricak, and V. Ponomarev
A New Acycloguanosine-Specific Supermutant of Herpes Simplex Virus Type 1 Thymidine Kinase Suitable for PET Imaging and Suicide Gene Therapy for Potential Use in Patients Treated with Pyrimidine-Based Cytotoxic Drugs
J. Nucl. Med., May 1, 2008; 49(5): 713 - 720.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Culver, W. Akers, and S. Achilefu
Multimodality Molecular Imaging with Combined Optical and SPECT/PET Modalities
J. Nucl. Med., February 1, 2008; 49(2): 169 - 172.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.